FDA Panel Strongly Endorses Oceana's Solesta Fecal Incontinence Product
This article was originally published in The Gray Sheet
Executive Summary
An FDA advisory panel offered strong support Dec. 2 to Ocean Therapeutics' effort to win PMA approval for its Solesta injectable bulking agent for fecal incontinence.